Edition:
United States

People: GlaxoSmithKline PLC (GSK.L)

GSK.L on London Stock Exchange

1,469.60GBp
10 Dec 2018
Change (% chg)

32.20 (+2.24%)
Prev Close
1,437.40
Open
1,446.00
Day's High
1,476.00
Day's Low
1,435.80
Volume
15,883,021
Avg. Vol
8,193,921
52-wk High
1,648.80
52-wk Low
1,235.20

Connor, Roger 

Mr. Roger Connor is re designated as President - Vaccines of the company effective from 1 September, 2018. He is no longer President - Global Manufacturing & Supply of Glaxosmithkline PLC effective from 1 September, 2018. He joined CET in 2012 and was appointed President, Global Manufacturing & Supply in 2013, after working for a year as President Designate. Prior to this, he was Vice President, Office of the CEO and Corporate Strategy. Roger joined GSK in 1998 from AstraZeneca. He was appointed to the Board of GSK Consumer Healthcare, our joint venture with Novartis, in April 2017. Roger holds a degree in Mechanical and Manufacturing Engineering from Queen’s University Belfast and a Masters in Manufacturing Leadership from Cambridge University. He is a Chartered Accountant.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Awards, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --